Heron Therapeutics | DEBITO

Prezzo Delle Azioni
1.30
Cambio Giornaliero
0.02 1.17%
Mensile
-13.09%
Annuale
-21.99%
Q1 Previsione
2.71




DEBITO Cambiamento Data
ALKERMES USD 72.68M 293.32M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 620.31M 1.25M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Eisai JPY 236.67B 49.14B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 564.56M 464K 2025-09
Ligand Pharmaceuticals USD 5.74M 5.72M 2025-06
Merck USD 41.37B 5.97B 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Omeros USD 442.16M 199K 2023-09
Pacira USD 376.72M 203.77M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Surmodics USD 29.55M 111K 2024-09
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Veracyte USD 50.65M 145K 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Heron Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.